Furthermore, during tumor angiogenesis, SRPK1 maintains the balance between the expression of the pro-angiogenic vascular endothelial growth factor (VEGF)-A165 and the anti-angiogenic VEGF-A165b [22]. The gene discussed is SRPK1; the disease is neoplasm.